1. Home
  2. CFFN vs EVO Comparison

CFFN vs EVO Comparison

Compare CFFN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capitol Federal Financial Inc.

CFFN

Capitol Federal Financial Inc.

HOLD

Current Price

$9.10

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$1.94

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFFN
EVO
Founded
1893
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
CFFN
EVO
Price
$9.10
$1.94
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
$7.25
$7.00
AVG Volume (30 Days)
793.2K
50.4K
Earning Date
04-29-2026
04-08-2026
Dividend Yield
4.51%
N/A
EPS Growth
79.31
N/A
EPS
0.32
N/A
Revenue
$16,300,000.00
N/A
Revenue This Year
$20.16
$1.37
Revenue Next Year
$6.62
$10.05
P/E Ratio
$27.63
N/A
Revenue Growth
6.54
N/A
52 Week Low
$5.72
$1.90
52 Week High
$9.10
$4.27

Technical Indicators

Market Signals
Indicator
CFFN
EVO
Relative Strength Index (RSI) 71.35 29.22
Support Level $7.49 N/A
Resistance Level N/A $3.84
Average True Range (ATR) 0.23 0.05
MACD 0.02 0.00
Stochastic Oscillator 79.41 24.32

Price Performance

Historical Comparison
CFFN
EVO

About CFFN Capitol Federal Financial Inc.

Capitol Federal Financial Inc is a bank holding company that operates through its wholly-owned subsidiary bank. The bank is a community-oriented financial institution that offers a variety of financial services through tens of locations. It mainly serves metropolitan areas within the state of Kansas. The bank performs traditional banking functions such as deposit-taking activities and investing that money in first-lien residential mortgages. It also participates in commercial real estate loans with other lenders, investing those funds in various securities. The vast majority of the bank's loan portfolio is in originated one- to four-family real estate loans. Its primary source of income is net interest income.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: